Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Interv Cardiol. 2007 Dec;20(6):447-57.

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.

Author information

  • 1UMass Marlborough Health System, Marlborough, Massachusetts, USA.

Abstract

Lipid-lowering therapy with statins reduces the risk of cardiovascular events in patients with established coronary heart disease (CHD). Traditionally, statins were perceived to lower the long-term cardiovascular risk by reducing elevated low-density lipoprotein cholesterol (LCL-C). Recently, this benefit has been established for patients early after acute coronary syndrome (ACS). The benefit appears linked to reductions in both LDL-C and C-reactive protein (CRP) that is a marker of systemic inflammation. This paper will review the current state of evidence from key recent statin trials in ACS and percutaneous coronary intervention (PCI) and discuss their significance for clinical practice.

PMID:
18042049
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk